How Analysts See UnitedHealth’s Story Shifting Amid Fresh Optimism and Ongoing Challenges

UnitedHealth Group’s stock has seen its consensus analyst price target edge up from $352.21 to $360.84, a move that reflects ...

Why Analysts Are Split as Nabors Industries’ Story Shifts With New Contracts and Guidance

Nabors Industries' stock narrative has shifted following a modest rise in its consensus analyst price target from $40.25 to $41.63. This adjustment, influenced by recent analyst updates and company ...
Fintel on MSN

Piper Sandler Maintains First Citizens BancShares, Inc. - Preferred Stock (FCNCO) Neutral Recommendation

Fintel reports that on October 24, 2025, Piper Sandler maintained coverage of First Citizens BancShares, Inc. - Preferred ...

Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference

Detailed price information for Immix Biopharma Inc (IMMX-Q) from The Globe and Mail including charting and trades.

What Catalysts Are Reshaping the Narrative for F5 After Recent Security and Growth Developments

F5’s consensus analyst price target has inched up from $330.82 to $333.00, hinting at slightly more optimistic expectations despite a shifting outlook. Recent analysis suggests that the modest ...

Notable analyst calls this week: HP, Dell and Enphase Energy among top picks

The S&P 500 (SP500) closed in the green on Friday, ending at a record high after cooler-than-expected consumer inflation ...